Managing SInHG in primary care: experiences and health outcomes
Research type
Research Study
Full title
Management of steroid-induced hyperglycaemia (SInHG) in primary care: An exploratory study to assess service user and clinicians’ experiences, treatment outcomes and their recommendations for optimal care.
IRAS ID
313155
Contact name
Nyangi Gityamwi
Contact email
Sponsor organisation
University of Surrey
Duration of Study in the UK
0 years, 8 months, 31 days
Research summary
Type 2 diabetes mellitus (T2DM) affects many peoples’ lives and costs the NHS nearly 10% of its annual budget. If not well managed, T2DM can lead to kidney failure, sight loss, leg amputation, stroke, heart attack and early death. T2DM causes harm through abnormally high levels of blood glucose (sugar). The use of steroid in treatment of conditions like Covid-19 pneumonia and cancer can make this worse. Although treatments are carried out in hospital to reduce blood glucose levels, about one-third of patients are likely to be sent home with high blood glucose. Afterwards, guidance from health care professionals nearer home is important for recovery.
Conversations with clinicians and someone who has first-hand experience of steroid-related high blood glucose suggest that there is anxiety in people particularly because of the risk of “hypo” (low blood glucose) when managing this condition at home.
Aim: To explore the experiences of patients, families and clinicians managing steroid-induced hyperglycaemia (SInHG) out of hospital, and co-identify steps that can be taken to improve care and support including the potential use of technology.
What we will do:
• Invite individuals known to have steroid-induced hyperglycaemia when discharged from the Surrey & Sussex Healthcare NHS Trust to participate in this study. We will also invite their family members and clinicians who support their care.
• Review patients’ care records and conduct interviews and focus group discussions.
• Invite patients, families and clinicians to an online workshop to help interpret the collected data and to identify points that are most important for actions and future research.REC name
South Central - Berkshire Research Ethics Committee
REC reference
22/SC/0263
Date of REC Opinion
8 Sep 2022
REC opinion
Further Information Favourable Opinion